Drug craving and other negative reactions after abrupt substitution of nefazodone for other serotonergic agents.
Castañeda
R
R
Levy
R
R
Westreich
L M
LM
Sussman
N
N
D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects* / Q000627:therapeutic use; D003511:Cyclohexanols / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005260:Female; D005473:Fluoxetine / Q000008:administration & dosage; D006801:Humans; D008297:Male; D017374:Paroxetine / Q000008:administration & dosage; D010879:Piperazines; D012008:Recurrence; D018490:Serotonin Agents / Q000008:administration & dosage*; D019966:Substance-Related Disorders / Q000188:drug therapy* / Q000209:etiology* / Q000523:psychology; D014230:Triazoles / Q000009:adverse effects* / Q000627:therapeutic use; D000069470:Venlafaxine Hydrochloride
D018687:Antidepressive Agents, Second-Generation; D003511:Cyclohexanols; D010879:Piperazines; D018490:Serotonin Agents; D014230:Triazoles; D005473:Fluoxetine; D017374:Paroxetine; C051752:nefazodone; D000069470:Venlafaxine Hydrochloride